Some breast cancer patients are facing a difficult situation in Turkey given recent local shortages of tamoxifen, which is used to treat hormone receptor-positive disease and is a first choice in the country for premenopausal women needing treatment. The estrogen-blocking drug is also used in postmenopausal women with breast cancer who cannot be treated with aromatase inhibitors.
For at least three months now, it has been very difficult to find generic tamoxifen, which is produced and imported...
Welcome to Pink Sheet
Create an account to read this article
Already a subscriber?